New balloon aims to clear clogged heart stents
NCT ID NCT07159087
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study compares a new drug-coated balloon (Genoss SCB) to an existing one (SeQuent Please NEO) for treating coronary arteries that have re-narrowed after stenting. About 94 adults with this condition will be randomly assigned to receive one of the two balloons during a standard heart procedure. The main goal is to see which balloon better keeps the artery open six months later, as measured by a special X-ray.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Sirolimus-coated balloon catheter (Genoss SCB) compared to Paclitaxel-coated balloon catheter (SeQuent Please NEO)
What this could lead to
If it works, this could offer a better option for treating re-narrowed heart arteries after stenting, potentially reducing the need for repeat procedures.
What could go wrong
This is a small, early-stage trial with only 94 patients. The new balloon may not prove superior or could have unexpected side effects. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERIAL DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Bundang Hospital
Gyeonggi-do, 13620, South Korea